Obesity medications in development
CJ Rebello, FL Greenway - Expert opinion on investigational drugs, 2020 - Taylor & Francis
Introduction: Obesity is compounded by a neurobiology that is resistant to weight loss.
Therefore, the development of pharmacotherapies to address the pathology underlying the …
Therefore, the development of pharmacotherapies to address the pathology underlying the …
Emerging pharmacotherapy for obesity
LJ Aronne, AG Powell, CM Apovian - Expert opinion on emerging …, 2011 - Taylor & Francis
Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …
tripled over the past three decades and are predicted to rise even further. The need for safe …
Pharmacotherapy for patients with obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical chemistry, 2018 - academic.oup.com
BACKGROUND Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon
G Srivastava, C Apovian - Current obesity reports, 2018 - Springer
Abstract Purpose of Review Obesity is a global health crisis with detrimental effects on all
organ systems leading to worsening disease state and rising costs of care. Persons with …
organ systems leading to worsening disease state and rising costs of care. Persons with …
[HTML][HTML] Approved and off-label uses of obesity medications, and potential new pharmacologic treatment options
ML Isidro, F Cordido - Pharmaceuticals, 2010 - mdpi.com
Available anti-obesity pharmacotherapy options remain very limited and development of
more effective drugs has become a priority. The potential strategies to achieve weight loss …
more effective drugs has become a priority. The potential strategies to achieve weight loss …
Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss
S Barja-Fernandez, R Leis, FF Casanueva… - Drug Design …, 2014 - Taylor & Francis
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the
adult population is obese in some countries. The excess of body fat is associated with …
adult population is obese in some countries. The excess of body fat is associated with …
Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies
VM Jackson, DA Price, PA Carpino - Expert opinion on …, 2014 - Taylor & Francis
Introduction: The discovery of new antiobesity agents has attracted considerable interest
over the past decade, but many of the investigational agents that have advanced into human …
over the past decade, but many of the investigational agents that have advanced into human …
The obesity epidemic: current and future pharmacological treatments
KG Hofbauer, JR Nicholson… - Annu. Rev. Pharmacol …, 2007 - annualreviews.org
The unabated rise in the prevalence of obesity is a challenge for global health care systems.
Efforts to reverse this trend by dietary or behavioral counseling have not been successful …
Efforts to reverse this trend by dietary or behavioral counseling have not been successful …
Pharmacologic treatment options for obesity: current and potential medications
K Fujioka, MW Lee - Nutrition in Clinical Practice, 2007 - Wiley Online Library
Pharmacotherapy has a role in obesity management when combined with diet, physical
activity, and behavior modification. Currently available therapies are safe when used …
activity, and behavior modification. Currently available therapies are safe when used …
Pharmacotherapy for obesity: novel agents and paradigms
Public health initiatives focused on obesity prevention and lifestyle intervention programmes
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …